Reversible cognitive decline during high-dose α-interferon treatment
- 30 April 1994
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 47 (4) , 901-905
- https://doi.org/10.1016/0091-3057(94)90294-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Neuropsychiatric symptoms during treatment with interleukin-2The Lancet, 1993
- Cognitive impairment in amyotrophic lateral sclerosis and its relation to motor disabilitiesActa Neurologica Scandinavica, 1990
- Effects of interferon alpha on performance in man: a preliminary reportPsychopharmacology, 1988
- Behavioral assessment of patients treated with alpha‐interferonActa Psychiatrica Scandinavica, 1988
- Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosisActa Neurologica Scandinavica, 1985
- Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancerPublished by American Medical Association (AMA) ,1984
- Central nervous system toxicity of interferonBritish Journal of Cancer, 1983
- Neurological effects of recombinant human interferon.BMJ, 1983
- A Standardized Memory Scale for Clinical UseThe Journal of Psychology, 1945